Pediatrix Medical Group, Inc. (MD) — Analysis Summary
Pediatrix Medical Group, Inc. (MD) has a market cap of $2.15B with year-over-year revenue growth of -4.9%. Net margin stands at 8.6%. The stock trades at a P/E ratio of 12.3.
Key Takeaways
- Revenue changed -4.9% year-over-year
- Net margin of 8.6%
- P/E ratio of 12.3
Compared to other companies in the SERVICES-HOSPITALS sector, MD posted revenue growth of -4.9% and trades at a P/E of 12.3.
Pediatrix Medical Group, Inc. (MD)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Operating margin (11.3%) exceeds gross margin (0.0%) — check for other operating income or data classification issues
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Sector
SERVICES-HOSPITALS
Employees
2,260
Headquarters
SUNRISE, FL
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.